ClinicalTrials.gg
RecruitingNCT07690267Updated Jul 9, 2026

Continuous Vital Sign Monitoring in a Surgical Ward

An observational study in Patient Monitoring, Wearable Devices and Telemonitoring, sponsored by University Hospital, Akershus. Recruiting at 1 site in Norway. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-09.

Sponsored by University Hospital, Akershus · Observational

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year 2 months later.
Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
9,600
Ages
18 Years and older
Sex
All
01

Study summary

Unsafe patient care remains a major contributor to global morbidity and mortality. In surgical wards, postoperative patients are typically monitored intermittently using the National Early Warning Score (NEWS-2), leaving periods during which clinical deterioration may go undetected. Continuous vital sign monitoring (CVSM) using wearable sensors offers the potential for earlier identification of deterioration compared with intermittent assessments.

CVSM was introduced in a hospital ward as part of a hospital-initiated pilot implementation and is used alongside standard monitoring with NEWS-2. The purpose of the study is to evaluate this implementation.

This observational study uses a pragmatic, quasi-experimental, multi-method, longitudinal design. The overall aims of the study are to evaluate the impact of CVSM implementation on patient outcomes, to explore healthcare professionals' perceptions of patient safety culture, turnover intention and pleasure of work, and to describe their experiences with implementation.

Read the detailed description

Unsafe care is a major contributor to global morbidity and mortality. In surgical wards, postoperative patients are typically monitored intermittently using the National Early Warning Score (NEWS-2), which may leave periods during which changes in vital signs go undetected, potentially increasing the risk of clinical deterioration. Continuous vital sign monitoring (CVSM) using wearable sensors may enable earlier detection of deterioration compared with intermittent monitoring.

This study evaluates the implementation of CVSM using 16 wearable sensors in a 29-bed gastro-surgical ward beginning in September 2025. CVSM is based on wearable sensors that continuously monitor patients' respiratory rate, heart rate, and oxygen saturation. The system transfers data to the electronic health record, and alerts are generated when predefined thresholds are exceeded and delivered to nursing staff via smartphones and workstation monitors. CVSM is implemented in addition to usual care, including intermittent NEWS-2 monitoring, in accordance with hospital protocol.

The intervention was implemented as part of a hospital-initiated pilot programme that was supported by hospital management and aimed to evaluate the feasibility and potential effects of broader CVSM adoption. The intervention ward was selected by the hospital for pragmatic reasons, based on managers' agreement to implement CVSM. Implementation was overseen by a hospital-appointed project manager. Members of the research team participated in implementation meetings and provided input on potential implementation strategies. However, responsibility for implementation decisions remained with hospital management and the clinical departments, and implementation was primarily guided by clinical priorities and operational constraints within the hospital. The primary role of the research team was to support and conduct the empirical evaluation of the intervention and its implementation.

It is hypothesised that CVSM may enable earlier detection of patient deterioration compared with intermittent monitoring alone and thereby influence patient outcomes. It is also hypothesised that CVSM may influence healthcare professionals' perceptions of patient safety culture, turnover intention, and work-related well-being. The study will further generate knowledge about healthcare professionals' experiences with the implementation.

While data collection for the studies on patient safety culture and nurses' experiences with implementation has started, the patient outcome study is currently awaiting a decision from the Norwegian Directorate of Health. Data collection for this study has not yet commenced. The studies on patient safety culture and nurses' experiences with implementation have been preregistered in the Open Science Framework (OSF).

02

Conditions studied

  • Patient Monitoring
  • Wearable Devices
  • Telemonitoring
  • Patient Safety
  • Patient Deterioration
  • Nurses
  • Healthcare Professionals
  • Work-related Outcomes
  • Implementation
  • Implementation Research

Keywords

  • Continuous vital sign monitoring
  • Patient monitoring
  • Wearable devices
  • Telemonitoring
  • Patient safety
  • Patient deterioration
  • Early warning scores
  • National Early Warning Score (NEWS-2)
  • Nurses
  • Healthcare professionals
  • Patient safety culture
  • Hospital Survey on Patient Safety Culture (HSOPSC 2.0)
  • Employee motivation
  • Work-related outcomes
  • Implementation
  • Technology implementation
  • Quasi-experimental design
  • Focus group interview
  • qualitative study
  • SEIPS
  • Digital health
  • Gastro-surgical ward
  • Postoperative patients
03

In context

Lead sponsor

University Hospital, Akershus is the lead sponsor of 125 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population includes adult patients admitted to a gastro-surgical ward before and after implementation of continuous vital sign monitoring (CVSM), as well as adult patients admitted to a non-equivalent comparison ward at the same Norwegian teaching hospital. The study population also includes healthcare professionals working in these wards.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18 years or older admitted to the gastro-surgical ward.
  • Healthcare professionals aged 18 years or older employed in the participating wards for survey participation.
  • Nursing staff with at least 6 months of work experience and experience using CVSM for participation in qualitative focus group interviews.

Exclusion criteria

Exclusion Criteria:

  • Patients with delirium.
  • Patients with cognitive impairment interfering with sensor use.
  • Patients who decline participation.
  • Patients with allergy to electrode adhesives.
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
9,600 participants (estimated)
Patient registry
No

Groups and cohorts

  • Intervention ward

    All patients admitted to the gastro-surgical ward during the 12-month implementation of continuous vital sign monitoring (CVSM). Healthcare professionals (physicians, nursing assistants, and registered nurses) working predominantly in the intervention ward.

    Other: Continuous Vital Sign Monitoring (CVSM)

  • Control group

    All patients admitted to the same gastro surgical ward will be its own control group 1 year before the intervention. Patients received standard care before the intervention. This means that relevant outcomes during the implementation (2026) is compared to the same outcomes before the intervention (i.e., 2024) in the same ward.

  • Non-equivalent comparison group

    All patients admitted to a non-equivalent comparison ward for the period spanning from January 1, 2024, to January 1, 2025, and from October 1, 2025, to October 1, 2026, during which CVSM was not implemented. Healthcare professionals (physicians, nursing assistants, and registered nurses) working predominantly in a comparable gastro-surgical ward at the same hospital during the 12-month implementation period of CVSM in the intervention ward.

Interventions

  • OtherContinuous Vital Sign Monitoring (CVSM)

    The intervention consists of continuous vital sign monitoring (CVSM) using wearable sensors applied to patients. A total of 16 sensors are implemented in a 29-bed gastro-surgical ward. The system continuously records patients' vital signs and transfers data to the electronic health record. Alerts are generated when predefined thresholds are exceeded and are delivered to nursing staff via smartphones and workstation monitors. The intervention is implemented in addition to usual practice with intermittent monitoring using the National Early Warning Score (NEWS-2), according to hospital protocol. Nursing staff receive training prior to implementation, and clinical responses to alerts are managed in accordance with hospital procedures. The intervention was implemented from September 2025 and continues during the study period.

06

What researchers measure

Primary outcomes

  1. NEWS-2 Associated with RRT Activation

    National Early Warning Score 2 (NEWS2) associated with rapid response team (RRT) activation. NEWS2 is a physiological deterioration score ranging from 0 to 20 points. Higher scores indicate greater physiological deterioration and worse clinical status. According to hospital protocol, RRT consultation is recommended at NEWS2 ≥7. NEWS2 at the time of RRT activation will be assessed.

    Time frame: Up to 12 months after implementation

  2. Patient Safety Culture (N-HSOPSC 2.0)

    Healthcare professionals' perceptions of patient safety culture measured as changes in the ten composite dimensions and two single-item measures of the Norwegian Hospital Survey on Patient Safety Culture (N-HSOPSC 2.0). Responses are recorded using 5-point Likert scales ranging from 1 to 5. Higher scores indicate more positive perceptions of patient safety culture.

    Time frame: Baseline, 5 months, and 12 months after implementation

  3. Nursing Staff Experiences with CVSM

    Nursing staff experiences with the implementation and perceived usefulness of continuous vital sign monitoring (CVSM) for patient safety, explored through qualitative focus group interviews. This is a qualitative outcome measure and no numerical score will be calculated.

    Time frame: Approximately 6 months after implementation

Secondary outcomes

  1. Rapid Response Team (RRT) Activation

    Number of Rapid Response Team (RRT) activation

    Time frame: Up to 12 months after implementation

  2. Unplanned Transfers to Higher Level of Care

    Number of unplanned transfers to a higher level of care (intensive care unit or postoperative care unit)

    Time frame: Up to 12 months after implementation

  3. NEWS-2 at Time of Clinical Deterioration

    National Early Warning Score 2 (NEWS2) measured at the time of unplanned transfer to a higher level of care. NEWS2 is a physiological deterioration score ranging from 0 to 20 points. Higher scores indicate greater physiological deterioration and worse clinical status.

    Time frame: Up to 12 months after implementation

  4. Hospital Length of Stay

    Total hospital length of stay (hours)

    Time frame: Up to 12 months after implementation

  5. Pleasure of Work and Turnover Intention

    Healthcare professionals' perceived pleasure of work and turnover intention measured using validated composite measures. Pleasure of work is assessed on a 4-point Likert scale (1-4) and turnover intention on a 5-point Likert scale (1-5). Higher scores indicate greater pleasure of work and lower turnover intention.

    Time frame: Baseline, 5 months, and 12 months after implementation

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared due to legal and ethical restrictions related to the use of sensitive patient and healthcare professional data. Study documents such as the protocol will be publicly available.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07690267
Responsible party
Gørill Birkeli (Senior Advisor, Administration; Postdoctoral Researcher, University Hospital, Akershus) — Principal investigator
First posted
Jul 8, 2026
Start date
Sep 1, 2025
Primary completion
Oct 1, 2026 (estimated)
Completion
Oct 1, 2026 (estimated)
Last update
Jul 9, 2026

Study contacts

Gørill H. Birkeli, PhD
Contact
gobi@ahus.no
+47 47304895
Gørill H. Birkeli, PhD
principal investigator · University Hospital, Akershus

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion